• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于低风险的子宫体癌,不建议进行系统性淋巴结清扫术。

Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer.

作者信息

Hidaka Takao, Nakashima Akitoshi, Shima Tomoko, Hasegawa Toru, Saito Shigeru

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.

出版信息

Obstet Gynecol Int. 2010;2010:490219. doi: 10.1155/2010/490219. Epub 2010 Feb 4.

DOI:10.1155/2010/490219
PMID:20168975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2820258/
Abstract

Objective. The objective of this study is to ascertain whether omission of lymphadenectomy could be possible when uterine corpus cancer is considered low-risk based on intraoperative pathologic indicators. Patient and Methods. Between 1998 and 2007, a total of 83 patients with low risk corpus cancer (endometrioid type, grade 1 or 2, myometrial invasion <==50%, and no intraoperative evidence of macroscopic extrauterine spread, including pelvic and paraaortic lymph node swelling and adnexal metastasis) underwent the total abdominal hysterectomy and bilateral salpingo-oophorectomy without lymphadenectomy. A retrospective review of the medical records was performed, and the disease-free survival (DFS), overall survival (OS), peri- and postoperative morbidities and complications were evaluated. Results. The 5-year DFS rates and the 5-year OS rates were 97.6% and 98.8%, respectively. No patient presented postoperative leg lymphedema and deep venous thrombosis. Conclusion. Omission of lymphadenectomy did not worsen the DFS or OS. The present findings suggest that systemic lymphadenectomy could be omitted in low-risk endometrial carcinoma.

摘要

目的。本研究的目的是确定当基于术中病理指标认为子宫体癌为低风险时,是否可以省略淋巴结切除术。患者与方法。1998年至2007年间,共有83例低风险子宫体癌患者(子宫内膜样型,1级或2级,肌层浸润<=50%,且术中无肉眼可见的子宫外播散证据,包括盆腔和腹主动脉旁淋巴结肿大及附件转移)接受了全腹子宫切除术和双侧输卵管卵巢切除术,未进行淋巴结切除术。对病历进行了回顾性分析,并评估了无病生存期(DFS)、总生存期(OS)、围手术期和术后发病率及并发症。结果。5年DFS率和5年OS率分别为97.6%和98.8%。无患者出现术后腿部淋巴水肿和深静脉血栓形成。结论。省略淋巴结切除术并未使DFS或OS恶化。目前的研究结果表明,低风险子宫内膜癌可省略系统性淋巴结切除术。

相似文献

1
Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer.对于低风险的子宫体癌,不建议进行系统性淋巴结清扫术。
Obstet Gynecol Int. 2010;2010:490219. doi: 10.1155/2010/490219. Epub 2010 Feb 4.
2
Omission of lymphadenectomy is possible for low-risk corpus cancer.对于低风险的子宫内膜癌,可不进行淋巴结切除术。
Eur J Surg Oncol. 2007 Feb;33(1):86-90. doi: 10.1016/j.ejso.2006.09.035. Epub 2006 Nov 13.
3
Lymphadenectomy for low-risk endometrial cancer based on preoperative and intraoperative assessments.基于术前和术中评估的低风险子宫内膜癌淋巴结切除术
Int J Gynecol Cancer. 2009 May;19(4):657-61. doi: 10.1111/IGC.0b013e3181a1319a.
4
Does tumor size have prognostic value in patients undergoing lymphadenectomy in endometrioid-type endometrial cancer confined to the uterine corpus?肿瘤大小对于局限于子宫体的子宫内膜样型子宫内膜癌行淋巴结切除术的患者是否具有预后价值?
Turk J Med Sci. 2019 Oct 24;49(5):1403-1410. doi: 10.3906/sag-1902-224.
5
Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients.淋巴结切除术对低风险子宫内膜癌患者无病生存期和总生存期的作用。
Ginekol Pol. 2018;89(6):311-315. doi: 10.5603/GP.a2018.0053.
6
Low-grade endometrial stromal sarcoma: A Turkish uterine sarcoma group study analyzing prognostic factors and disease outcomes.低级别子宫内膜间质肉瘤:土耳其子宫肉瘤协作组分析预后因素和疾病结局的研究。
Gynecol Oncol. 2021 Mar;160(3):674-680. doi: 10.1016/j.ygyno.2020.12.017. Epub 2020 Dec 27.
7
Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.系统腹膜后淋巴结清扫术联合辅助化疗治疗子宫内膜癌合并腹主动脉旁淋巴结转移患者的长期生存。
Int J Gynecol Cancer. 2010 Aug;20(6):1000-5. doi: 10.1111/IGC.0b013e3181d80aff.
8
Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.低风险子宫内膜癌患者是否需要手术分期?一项回顾性临床分析。
Asian Pac J Cancer Prev. 2015;16(13):5331-5. doi: 10.7314/apjcp.2015.16.13.5331.
9
Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.基于盆腔淋巴结清扫彻底程度对子宫内膜样型子宫内膜癌中高危组生存影响的多中心回顾性队列分析。
Gynecol Oncol. 2016 Jun;141(3):440-446. doi: 10.1016/j.ygyno.2016.03.031. Epub 2016 Apr 8.
10
Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.子宫内膜癌前哨淋巴结活检——可行性、安全性和淋巴并发症。
Gynecol Oncol. 2018 Mar;148(3):491-498. doi: 10.1016/j.ygyno.2017.12.017. Epub 2017 Dec 20.

引用本文的文献

1
The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients.表观扩散系数在评估Ⅰ期子宫内膜癌患者高危因素及预后中的卓越价值
Front Oncol. 2022 Feb 16;12:820904. doi: 10.3389/fonc.2022.820904. eCollection 2022.
2
Effect of Pelvic Lymphadenectomy on Survival in Patients with Low-Risk Early-Stage Endometrial Cancer Diagnosed Intraoperatively Using Frozen Tissue Sections: A Retrospective Analysis.盆腔淋巴结清扫术对术中采用冰冻组织切片诊断的低风险早期子宫内膜癌患者生存的影响:一项回顾性分析
Cancer Manag Res. 2020 Oct 29;12:10715-10723. doi: 10.2147/CMAR.S274992. eCollection 2020.
3

本文引用的文献

1
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
2
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.子宫内膜癌系统性盆腔淋巴结清扫术的疗效(MRC ASTEC试验):一项随机研究
Lancet. 2009 Jan 10;373(9658):125-36. doi: 10.1016/S0140-6736(08)61766-3. Epub 2008 Dec 16.
3
Accuracy of frozen section diagnosis at surgery in pre- malignant and malignant lesions of the endometrium.子宫内膜癌前病变和恶性病变手术中冰冻切片诊断的准确性。
The prognostic significance of preoperative serum cancer antigen 15-3 levels in endometrial carcinomas.
子宫内膜癌患者术前血清癌抗原15-3水平的预后意义
Saudi Med J. 2017 Nov;38(11):1096-1100. doi: 10.15537/smj.2017.11.20479.
4
Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations.利用体细胞突变将子宫内膜样子宫内膜癌患者分层为不同风险水平。
Gynecol Oncol. 2016 Jul;142(1):150-157. doi: 10.1016/j.ygyno.2016.05.012. Epub 2016 May 16.
5
Selective lymphadenectomy in endometrial cancer: Retrospective analysis of morbidity and survival data at a tertiary care centre.子宫内膜癌的选择性淋巴结切除术:三级医疗中心发病率和生存数据的回顾性分析
Pak J Med Sci. 2015 Jul-Aug;31(4):950-5. doi: 10.12669/pjms.314.7593.
6
A cohort study evaluating paraaortic lymphadenectomy in endometrial cancer.一项评估子宫内膜癌腹主动脉旁淋巴结切除术的队列研究。
Oncol Lett. 2012 Dec;4(6):1361-1365. doi: 10.3892/ol.2012.919. Epub 2012 Sep 17.
7
Asian society of gynecologic oncology workshop 2010.亚洲妇科肿瘤学会 2010 年研讨会。
J Gynecol Oncol. 2010 Sep;21(3):137-50. doi: 10.3802/jgo.2010.21.3.137. Epub 2010 Sep 28.
Eur J Gynaecol Oncol. 2008;29(5):435-40.
4
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.早期子宫内膜癌系统性盆腔淋巴结清扫术与未行淋巴结清扫术的比较:随机临床试验
J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.
5
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.根据国际妇产科联盟(FIGO)分期,子宫内膜样组织学类型的子宫内膜腺癌患者经充分手术分期后盆腔淋巴结转移的发生率。
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):269-73. doi: 10.1111/j.1525-1438.2007.00996.x.
6
Omission of lymphadenectomy is possible for low-risk corpus cancer.对于低风险的子宫内膜癌,可不进行淋巴结切除术。
Eur J Surg Oncol. 2007 Feb;33(1):86-90. doi: 10.1016/j.ejso.2006.09.035. Epub 2006 Nov 13.
7
Surgical staging for patients presenting with grade 1 endometrial carcinoma.1级子宫内膜癌患者的手术分期
Obstet Gynecol. 2005 Mar;105(3):487-93. doi: 10.1097/01.AOG.0000149151.74863.c4.
8
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.紫杉醇、卡铂联合氨磷汀治疗晚期、复发性或难治性子宫内膜腺癌:西南肿瘤协作组的一项II期研究
Gynecol Oncol. 2005 Mar;96(3):610-5. doi: 10.1016/j.ygyno.2004.11.024.
9
Predictors of final histology in patients with endometrial cancer.子宫内膜癌患者最终组织学的预测因素。
Gynecol Oncol. 2004 Dec;95(3):463-8. doi: 10.1016/j.ygyno.2004.07.016.
10
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.多柔比星联合顺铂加或不加紫杉醇及非格司亭用于晚期子宫内膜癌的Ⅲ期试验:一项妇科肿瘤学组研究
J Clin Oncol. 2004 Jun 1;22(11):2159-66. doi: 10.1200/JCO.2004.07.184.